Top pharmaceutical companies in the U.S. and Europe have said they are halting recruitment for clinical trials in Russia, while continuing to send medicine and other health supplies to help those in need.
Drugmakers including Pfizer Inc., Johnson & Johnson, Merck & Co., Roche Holding Ag and Bristol Myers Squib Co. are seeking to strike a balance between international opprobrium over Russia’s invasion of Ukraine and the needs of sick patients.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.